Testing a New Blood Pressure Device for Newborns
Part of Heart & circulation clinical trials.
This study tests a new device called Boppli that measures blood pressure in babies in the intensive care unit. It's designed for newborns who are at risk for high blood pressure due to kidney problems or other serious conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is currently in the neonatal intensive care unit (NICU)
- Your baby is younger than 9 months old and weighs less than 5 kg (about 11 pounds)
- Your baby has risk factors for high blood pressure, such as kidney injury, kidney disease, or a history of life support machines
- You are the parent or legal guardian and able to give permission for the study
- Your baby is not currently on a heart pump (ventricular assist device) or machines that filter blood outside the body
- Your baby's skin and body allow doctors to safely place the blood pressure measurement device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-invasive blood pressure device in babies, children, and teens. It compares the device's readings to those from an arterial line, which is already in place for their medical care. The goal is to see if the device can measure blood pressure accurately without needles.
This trial compares two medicines (dopamine and norepinephrine) to see which works better for raising blood pressure in newborns who have both low blood pressure and high blood pressure in the lungs. Both medicines are given through a vein to help stabilize your baby's blood pressure.
This study tests whether a new Withings blood pressure monitor (BPM Pro 2) accurately measures blood pressure in pregnant women, including those with pregnancy-related high blood pressure (preeclampsia). Accurate home blood pressure monitoring could help keep you and your baby safer during pregnancy.
This trial tests a new noninvasive method to monitor blood pressure in newborns using light sensors on the scalp. It aims to understand if this device, called FlexNIRS, can accurately track blood pressure without needing an arterial line or frequent cuff measurements.
This trial uses a new ultrasound device (NeoDoppler) to watch blood flow in a baby's brain continuously. It aims to see if this gentle, bedside tool can help doctors monitor babies—especially those born early or with certain health concerns—without moving them.
This trial tests a program that lets you monitor your blood pressure at home after childbirth and learn about heart health. It's for women who had high blood pressure for the first time during pregnancy and are in the Ochsner system.
Hear when a new Hypertension, Neonatal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.